Paul M Vanhoutte
Paul M Vanhoutte
Chair Professor in Pharmacology, University of Hong Kong
Verified email at hku.hk
Title
Cited by
Cited by
Year
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
D Hoyer, DE Clarke, JR Fozard, PR Hartig, GR Martin, EJ Mylecharane, ...
Pharmacological reviews 46 (2), 157-203, 1994
36251994
Endothelium‐derived relaxing and contracting factors
RF Furchgott, PM Vanhoutte
The FASEB Journal 3 (9), 2007-2018, 1989
25871989
Flow-induced release of endothelium-derived relaxing factor
GM Rubanyi, JC Romero, PM Vanhoutte
American Journal of Physiology-Heart and Circulatory Physiology 250 (6 …, 1986
19091986
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
GM Rubanyi, PM Vanhoutte
American Journal of Physiology-Heart and Circulatory Physiology 250 (5 …, 1986
17091986
Endothelial dysfunction in diabetes
AS De Vriese, TJ Verbeuren, J Van de Voorde, NH Lameire, ...
British journal of pharmacology 130 (5), 963-974, 2000
13392000
Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.
TF Lüscher, PM Vanhoutte
Hypertension 8 (4), 344-348, 1986
10261986
Endothelium-dependent hyperpolarization of canine coronary smooth muscle.
M Feletou, PM Vanhoutte
British journal of pharmacology 93 (3), 515, 1988
9871988
Endothelial dysfunction: a multifaceted disorder (the Wiggers Award Lecture)
M Félétou, PM Vanhoutte
American Journal of Physiology-Heart and Circulatory Physiology 291 (3 …, 2006
9862006
Anti-inflammatory actions of steroids: molecular mechanisms
PJ Barnes, I Adcock, M Spedding, PM Vanhoutte
Trends in pharmacological sciences 14 (12), 436-441, 1993
9761993
EDHF: bringing the concepts together
R Busse, G Edwards, M Félétou, I Fleming, PM Vanhoutte, AH Weston
Trends in pharmacological sciences 23 (8), 374-380, 2002
9472002
The endothelium
TF Luscher, PM Vanhoutte
CRC press, 1990
8671990
Endothelium and control of vascular function. State of the Art lecture.
PM Vanhoutte
Hypertension 13 (6_pt_2), 658-667, 1989
8631989
Endothelial dysfunction and vascular disease
PM Vanhoutte, H Shimokawa, EHC Tang, M Feletou
Acta physiologica 196 (2), 193-222, 2009
8602009
Modulation of vascular smooth muscle contraction by the endothelium
PM Vanhoutte, GM Rubanyi, VM Miller, DS Houston
Annual Review of Physiology 48 (1), 307-320, 1986
8311986
Endothelium-derived hyperpolarizing factor: where are we now?
M Félétou, PM Vanhoutte
Arteriosclerosis, thrombosis, and vascular biology 26 (6), 1215-1225, 2006
824*2006
Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium.
JG De Mey, PM Vanhoutte
Circulation research 51 (4), 439-447, 1982
7331982
Endothelial dysfunction: from physiology to therapy
JV Mombouli, PM Vanhoutte
Journal of molecular and cellular cardiology 31 (1), 61-74, 1999
7311999
Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP
RA Cohen, PM Vanhoutte
Circulation 92 (11), 3337-3349, 1995
6451995
Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
JM Van Nueten, PAL Janssen, J Van Beek, R Xhonneux, TJ Verbeuren, ...
Journal of Pharmacology and Experimental Therapeutics 218 (1), 217-230, 1981
6431981
Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide
JM Lundberg
Pharmacol. Rev. 48, 113-178, 1996
6101996
The system can't perform the operation now. Try again later.
Articles 1–20